ImmuneTarget's Incubator/Accelerator Round

ImmuneTarget raised a round of funding on June 10, 2015. Investors include JLabs.

ImmuneTarget is developing targeted therapies for cancers and autoimmune diseases.…

Articles about ImmuneTarget's Incubator/Accelerator Round: